AstraZeneca

AstraZeneca: pharma needs to lead by example on sustainability
Pharmaforum
Thu, 03/26/20 - 10:13 am
AstraZeneca
sustainability
environmental concerns
AstraZeneca forges alliance with digital health firm BrightInsight
Pharmaforum
Wed, 03/25/20 - 11:53 pm
AstraZeneca
BrightInsight
digital health
chronic disease
Astra, Daiichi's Enhertu shows early promise in HER2 lung cancer
Fierce Biotech
Wed, 03/25/20 - 10:49 am
AstraZeneca
Daiichi Sankyo
Enhertu
clinical trials
HER2-positive non-small cell lung cancer
Silence Therapeutics Says Collaborating With Astrazeneca On siRNA Therapeutics
Reuters
Wed, 03/25/20 - 10:34 am
Silence Therapeutics
AstraZeneca
siRNA
drug development
cardiovascular disease
renal disease
respiratory disease
metabolic disorders
Go or no go? Covid-19 upstages US regulatory decisions
EP Vantage
Tue, 03/24/20 - 10:30 am
FDA
regulatory
Bristol-Myers Squibb
ozanimod
Esteve
E-58425
Fabre-Kramer
AstraZeneca
Imfinzi
Astellas
Vesicare
AbbVie
Neurocrine
Orlissa
Sanofi
MenQuadfi
opicapone
Acceleron
Reblozyl
Lilly and Boehringer's Jardiance, chasing AZ, nabs speedy FDA review in kidney disease
Fierce Pharma
Thu, 03/12/20 - 10:57 pm
Eli Lilly
Boehringer Ingelheim
AstraZeneca
FDA
Jardiance
kidney disease
AstraZeneca and Merck's string of Lynparza successes ends in ovarian cancer
BioPharma Dive
Thu, 03/12/20 - 12:58 pm
AstraZeneca
Merck
cediranib
ovarian cancer
clinical trials
Lynparza
Seattle could waltz in where Astra failed
EP Vantage
Fri, 03/6/20 - 10:34 am
AstraZeneca
Imfinizi
bladder cancer
Seattle Genetics
clinical trials
Padcev
Can reformulation of an AstraZeneca castoff rival Takeda's new heartburn drug? Here's a $26M bet on yes
Endpoints
Wed, 03/4/20 - 07:55 pm
Cinclus Pharma
AstraZeneca
heartburn
linaprazan
Takeda
acid reflux
AstraZeneca's HQ budget balloons to 3 times original forecast
Fierce Biotech
Wed, 03/4/20 - 10:39 am
AstraZeneca
headquarters
UK
AZ picks up $350m after selling hypertension drugs
Pharmaforum
Mon, 03/2/20 - 09:35 am
AstraZeneca
hypertension
Atnahs Pharma
AstraZeneca, still in asset-sale mode, hands off most global rights for constipation med Movantik
Fierce Pharma
Tue, 02/25/20 - 04:54 pm
AstraZeneca
Redhill Biopharma
constipation
Movantik
Empty AstraZeneca plant sized up by CDMO which may or may not be AGC Biologics
Fierce Pharma
Mon, 02/24/20 - 10:33 am
AstraZeneca
Colorado
Japan
AGC Biologics
drug manufacturing
CDMO
Blockbusters in waiting: drug launches to watch in 2020
Pharmaforum
Mon, 02/17/20 - 11:33 pm
drug launches
Biohaven
rimegepant
Novartis
ofatumumab
Celgene
ozanimod
Akebia Therapeutics
vadadustat
Biomarin
valrox
Gilead Sciences
filgotinib
Novo Nordisk
oral semaglutide
inclisiran
Immunomedics
sacituzumab govitecan
AstraZeneca
Enhertu
Bristol-Myers Squibb
liso-cel
AstraZeneca cans cancer pipeline efforts
Fierce Biotech
Fri, 02/14/20 - 10:49 am
AstraZeneca
earnings
R&D
cancer
oncology
AstraZeneca's Chinese investment bank partner raises $229M for its own new fund — and it's all about the coronavirus
Endpoints
Fri, 02/14/20 - 10:46 am
AstraZeneca
China
coronavirus
COVID-19
How a cocktail of existing drugs could regenerate insulin-producing cells in diabetes
Fierce Biotech
Thu, 02/13/20 - 10:44 am
diabetes
insulin
Mt Sinai
Novo Nordisk
Ozempic
Rybelsus
Victoza
Eli Lilly
Trulicity
AstraZeneca
Bydureon
Easing concerns, FibroGen, AstraZeneca secure FDA date for their anemia drug in broad chronic kidney disease population
Endpoints
Wed, 02/12/20 - 10:50 am
FibroGen
AstraZeneca
FDA
anemia
chronic kidney disease
roxadustat
AZ, Daiichi’s new cancer drug Enhertu gets off to the races with quick U.S. launch
Fierce Pharma
Mon, 02/10/20 - 11:42 pm
AstraZeneca
Daiichi Sankyo
clinical trials
FDA
Enhertu
cancer
breast cancer
AstraZeneca expanding again in Australia, pledging $133M investment at Sydney site and adding 250 jobs
Fierce Pharma
Fri, 02/7/20 - 11:58 pm
AstraZeneca
Australia
New Zealand
drug manufacturing
asthma
COPD

Pages